---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-021084"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T13:44:08.931508+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte Raises $816.5 Million in Public Offering of Common Stock and Pre-Funded Warrants

## Summary
- Underwriting agreement with BofA, Jefferies, Leerink, Evercore for 10,937,500 shares at $64.00 per share and 781,250 pre-funded warrants at $63.999 per warrant.
- Pre-funded warrants have an exercise price of $0.001 per share and are exercisable until fully exercised subject to an ownership limitation.
- Underwriters exercised option in full for an additional 1,757,812 shares, bringing total shares offered to 12,695,312.
- Net proceeds expected to be approximately $816.5 million after underwriting discounts and expenses.
- Closing expected on or about February 2, 2024, under effective registration statement on Form S-3.

## SEC filing metadata
- accession: 0001193125-24-021084
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000119312524021084/0001193125-24-021084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000119312524021084/d752729d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-021084
- JSON: https://secwatch.observer/filing/0001193125-24-021084.json
- Plain text: https://secwatch.observer/filing/0001193125-24-021084.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.